MDIs formulation [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2014-12-12 10:36 (4212 d 17:13 ago) – Posting: # 14061
Views: 3,260

Hi Mahesh M,

❝ do you have any reference for the same?


I don't.
I think it is a rather practical matter.

❝ We have to mention dosing procedure in protocol and if we not mention about 30 sec gap between two puffs, regulatory agency may ask for the same (means not follow the SPC with regards of dosing instruction)


Yes, you can e.g. write in your protocol that you are dosing approx. 30 secs apart and that t=0 is when the first puff is given.
By the way you don't always need to do everything strictly as per SPC for EU submissions. Other examples of SPC deviations in OIP studies include nose clips and total doses.

Good luck with your study.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
121 visitors (0 registered, 121 guests [including 9 identified bots]).
Forum time: 04:50 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5